Dr. Michael Koren & Kevin Geddings discuss Damar Hamlin's condition from the perspective of a cardiologist and clinical researcher. Listen in to hear new information from Dr. Koren in this 9-minute briefing on the MedEvidence Monday Minute.
Learn about:
💙 Commotio Cordis
💜Hypertrophic Cardiomyopathy
💚Atrial Fibrillation
Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center. On a personal note, Dr. Koren has a life-long interest in history, technology, Public Health, and music. He has written two musical plays.
More information and to Participate in Clinical Research
Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow MedEvidence! on Social Media to discover the Truth Behind the Data.
Facebook
Instagram
Twitter
LinkedIn
Powered by ENCORE Research Group at www.ENCOREDOCS.com
Original Air Date: January 9, 2023
#MedEvidence #clinicalresearch #clinicaltrials #research #research doctor #DamarHamlin #3 #Dr.Koren #commotiocordis #BuffaloBills #heartcondition #athlete #heartofathlete
